Search for: "Christopher Holder" Results 61 - 80 of 530
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Mar 2021, 8:00 am by Matthieu Dhenne (Ipsilon)
AI raises real questions, but they do not concern the right holder but the object of the right. [read post]
28 Mar 2021, 2:31 am by Matthieu Dhenne (Ipsilon)
AI raises real questions, but they do not concern the right holder but the object of the right. [read post]
26 Mar 2021, 7:06 am by Miquel Montañá (Clifford Chance)
The facts of the case can be summarized as follows: The claimants, a French manufacturer of automotive parts and its Spanish subsidiary, were the holder and licensee of the Spanish validations of European patents EP 764.811 (“EP ‘811”) and EP 933.254 (“EP ‘254”), which protect vehicle lighting or signaling devices having specific features. [read post]
26 Mar 2021, 6:09 am
Miles (The Miles Group), on Wednesday, March 24, 2021 Tags: Corporate culture, Corporate purpose, Corporate Social Responsibility, Diversity, ESG, Management, Stakeholders Behavioral Psychology Might Explain What’s Holding Boards Back Posted by Maria Castañón Moats, Paul DeNicola, and Leah Malone, PricewaterhouseCoopers LLP, on Thursday, March 25, 2021 Tags: Behavioral finance, Board composition, Board… [read post]
22 Mar 2021, 8:01 am by William Ford, Victoria Gallegos
The committee will hear testimony from Christopher Maier, acting assistant defense secretary for special operations and low-intensity conflict; Gen. [read post]
15 Mar 2021, 9:42 am by William Ford, Victoria Gallegos
The subcommittee will hear testimony from David Taylor, the senior official performing the duties of the undersecretary of defense for intelligence and security, and Christopher Maier, acting assistant defense secretary for special operations and low-intensity conflict. [read post]
11 Mar 2021, 2:41 am by Matthieu Dhenne (Ipsilon)
Ex officio licensing: a tool for access to medicines that should be mobilised A patent licence is a contract by which the patent holder – the patentee – grants a third party – the licensee – the right to exploit the invention in return for royalties. [read post]
9 Mar 2021, 3:48 am by Boris Malakhov (Lidings)
Similar registers have long been set up worldwide to settle disputes between patent holders and generic producers (e.g., the US Orange Book). [read post]
8 Mar 2021, 9:06 am by William Ford, Victoria Gallegos
FBI Director Christopher Wray will make opening remarks, and Suzanne Spaulding, senior adviser for homeland security at CSIS will lead a fireside chat. [read post]
8 Mar 2021, 1:20 am by Matthieu Dhenne (Ipsilon)
Sabotier (High Court): It is an essential tool for providing proof of infringement when this proof is not easily accessible to the right holder. [read post]
8 Mar 2021, 12:55 am by Matthieu Dhenne (Ipsilon)
Sabotier (High Court): It is an essential tool for providing proof of infringement when this proof is not easily accessible to the right holder. [read post]
While they are addressed at both SEP holders and implementers, they seem aimed at neutralising attempts by SEP owners to declare as many patents as possible as essential to specific standards. [read post]
4 Mar 2021, 10:00 pm
Associates Candace Polster and Richard Martin and partner Christopher Betti authored an article for Law360 regarding the Biologics Price Competition and Innovation Act. [read post]
4 Mar 2021, 10:00 pm
Associates Candace Polster and Richard Martin and partner Christopher Betti authored an article for Law360 regarding the Biologics Price Competition and Innovation Act. [read post]
4 Mar 2021, 10:00 pm
Associates Candace Polster and Richard Martin and partner Christopher Betti authored an article for Law360 regarding the Biologics Price Competition and Innovation Act. [read post]
4 Mar 2021, 10:00 pm
Associates Candace Polster and Richard Martin and partner Christopher Betti authored an article for Law360 regarding the Biologics Price Competition and Innovation Act. [read post]
4 Mar 2021, 10:00 pm
Associates Candace Polster and Richard Martin and partner Christopher Betti authored an article for Law360 regarding the Biologics Price Competition and Innovation Act. [read post]
4 Mar 2021, 10:00 pm
Associates Candace Polster and Richard Martin and partner Christopher Betti authored an article for Law360 regarding the Biologics Price Competition and Innovation Act. [read post]
3 Mar 2021, 4:58 pm by Boris Malakhov (Lidings)
The Decree is based on art. 1360 of the Russian Civil Code which entitles the Government to grant a compulsory license “in the interests of public security” without a patent holder’s consent subject to its notification and “a fair compensation”. [read post]
The report suggests (at page 169) to create an ‘appropriate mechanism and controls to allow licensee negotiation groups (industry associations representing member implementers or groups of individual implementers) to jointly negotiate licences with individual SEP holders and SEP patent pools without the risk of getting in conflict with antitrust regulation’. [read post]